Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

ReGen Biologics Receives NSE Letter from FDA, Proceeding with Next Steps to Gain U.S. Market Clearance (Business Wire via Yahoo! Finance)

HACKENSACK, N.J.—-ReGen Biologics, Inc. announced today that the company is in receipt of a not substantially equivalent letter from the U.S. Food and Drug Administration regarding the 510 submission for its Collagen Scaffold device.

More: continued here





You can respond, or trackback from your own site.


Related News

  • ReGen Biologics Responds to FDA Request for Additional Information on Pending 510(k) (Business Wire via Yahoo! Finance)
  • ReGen Biologics To Exhibit at 2007 AOSSM Annual Meeting (Business Wire via Yahoo! Finance)
  • Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of ... (Business Wire via Yahoo! Finance)
  • Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix (PrimeNewswire via Yahoo! Finance)
  • TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction (PR Newswire via Yahoo! Finance)
  • TEI Biosciences gets FDA OK for expanded use of product (BizJournals)
  • FDA Approves CustomVue Monovision LASIK (U. S. Food and Drug Administration)
  • Pegasus Biologics' OrthADAPT(TM) Bioimplant Receives CE Mark (Business Wire via Yahoo! Finance)
  • Covidien gets FDA approval for surgery kit (AP via Yahoo! Finance)
  • STAAR Surgical Submits Application to FDA for the Visian Toric ICL


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us